3.83 USD
▼-0.06-1.42%
盘后 3.70 -4.64%
2026-09-08
市值
$4.64M
市盈率
—
EPS
-14.11
股息率
—
52 周区间
3.29 – 13.20
成交量
4.10K
Beta
0.67
目标价
—
52W 低 3.2952W 高 13.20
价格走势
公司简介
Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases and related indications. The company develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule which is in a Phase III study for oral treatment for non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company also evaluates Aramchol through the ARRIVE Study, a Phase IIa clinical trial with HIV-associated...